|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 32.00 | ACUITE A | Stable | Reaffirmed | - |
| Bank Loan Ratings | 68.00 | - | ACUITE A1 | Reaffirmed |
| Total Outstanding | 100.00 | - | - |
|
Rating Rationale |
|
Acuite has reaffirmed long-term rating of 'ACUITE A' (read as ACUITE A ) and short-term rating of 'ACUITE A1' (read as ACUITE A one) on the Rs.100.00 crore bank facilities of Tanfac Industries Limited (TIL). The outlook is 'Stable' Rationale for Rating The rating factors in the continuous improvement in business operations of the company revenue of company stood at Rs.381.34 Cr.in FY24 as against Rs.379.36 Cr. in FY23. The growth in revenue is driven by increased volume and realisation of hydrofluoric acid and business synergies with Anupam Rasayan India Limited (ARIL) wherein key raw material is being procured from TIL. As a result of higher demand the company is undergoing Capex of ~Rs. 105.00 cr. for doubling the HF capacity. Further,the rating factors in the strong financial risk profile of the company as reflected by the debt free position and improving networth of the company. Also, the liquidity of the company continued to remain strong with adequate net cash accruals against no debt obligations and no utilization of fund-based limits. The growth in business and strong financial risk profile of the company is expected to continue in the near future due to better demand for its product and minimal dependence on external borrowings for the CAPEX. However, the rating is constrained basis the company being in a competitive and fragmented industry with multiple mid-size to large size players. Further the company is dealing in hazardous products which have its own challenges. |
| About the Company |
|
TIL was incorporated in 1972 by Tamil Nadu Industrial Development Corporation (TIDCO) as a joint sector company along with Mr. L. Narayanan Chettiar. In 1980, Aditya Birla Group (ABG) bought out the 25.00 percent stake from Mr. Chettiar, thereby becoming the co-promoter of TIL. However, in March 2022, Anupam Rasayan India Limited (ARIL) acquired Birla Group Holdings Private Limited's stake and became the co-promoter of the company with TIDCO. TIL is engaged in the manufacturing of inorganic fluorine-based chemicals such as Anhydrous Hydrofluoric acid, Sulphuric Acid, Oleum, Aluminium Fluoride, Potassium Fluoride, Potassium Bifluoride, Boron Trifluoride Complexes, Calcium Sulphate (Gypsum), IsoButyl Acetophenone, Acetic Acid, Peracetic Acid and Poly Aluminium Chloride, etc. TIL is listed on the Bombay Stock Exchange (BSE).
|
| Unsupported Rating |
| Not Applicable |
| Analytical Approach |
|
Acuité has considered the standalone business and financial risk profiles of the TIL to arrive at this rating.
|
| Key Rating Drivers |
| Strengths |
| Long track record of operations and experienced management TIL was incorporated in 1972 as a joint sector company between Tamil Nadu Industrial Development Corporation (TIDCO) and Mr. L. Narayanan Chettiar. In 1980, Aditya Birla Group, an India multinational conglomerate invested in TIL, thereby acquiring 25.00 percent stake from Mr. Chettiar. The management control of the company was vested with Aditya Birla Group (ABG). However, Aditya Birla Group Holdings Private Limited sold its stake to Anupam Rasayan India Limited (ARIL) in March 2022, resultantly making ARIL the co-promoter along with TIDCO of TIL. The company is engaged in the manufacturing of inorganic fluorine-based chemicals which have vital applications in industries such as aluminium smelting, petroleum refining, refrigerant gases, steel re-rolling, glass, ceramics, sugar, fertilizers, and heavy water. Its manufacturing facility is situated at Cuddalore. Furthermore, the company has well established operations with senior management and directors who have decades of experience in the aforementioned line of business. Over the years, the company has established a reputation in the chemical industry. TIL is a public company listed on the Bombay Stock Exchange. Acuité believes support from ARIL provides comfort to the business and management risk profile of the company and the long track record of operations with management's extensive experience helps the company maintain healthy and long-standing relations with customers and suppliers. Healthy Financial Risk Profile TIL's financial risk profile continued to remain healthy marked by healthy net worth, nil gearing and healthy debt protection metrics. The net worth of the company stood at Rs. 230.45 crore as on March 31, 2024 against Rs. 184.27 crore as on March 31, 2023. The improvement is on account of accretion of profit to reserves. The gearing of the company stood nil as on March 31, 2024 as the company remained to be a debt free company. Tanfac Industries Limited is essentially debt-free with no long-term borrowings. Whilst the Company has availed the banking facilities of fund-based and non-fund based, it is however utilising only non-fund based debt facilities in the form of Letter of Credit. Further, the Cash Credit facility that the company has availed is not being utilised. The interest coverage ratio of TIL remained comfortable and stood at 106.52 times for FY 2024 against 37.26 times for FY 2023. The TOL/TNW ratio stood at 0.31 times as on March 31, 2024 against 0.37 times as on March 31, 2023. Going forward the leverage of the company is expected to moderate however still remain strong and below unity as the company is undertaking a CAPEX of ~Rs. 105.00 cr. to double the HF capacity which will be funded by Rs. 30 Cr. debt and remaining from internal sources. Moderately intensive working capital cycle Marked by GCA days of 130 the company’s working capital intensity is moderate however the working capital cycle albeit moderated remains comfortable at 56 days in FY24. The inventory days of the company in FY24 stood at 70 days i.e. a minuscule increase from 65 days in FY23 likewise the debtor days increased from 49 days in FY23 to 59 days in FY24.. Although the company’s working capital cycle is moderate company’s fund based limits remains unutilized giving liquidity cushion in the form of undrawn limits of Rs. 22 Cr.
|
| Weaknesses |
| Competitive and fragmented industry The company is in the chemical compounds sector and faces intense competition marked by the presence of several mid to large size players. The company faces intense competition from peers and international players. However, this risk is mitigated to an extent as the company is operating in this environment for almost five decades now and the company has an established track record and a brand name. |
| Rating Sensitivities |
|
| Liquidity Position |
| Strong |
| TIL has strong liquidity marked by healthy net cash accruals to its maturing debt obligations. The company generated cash accruals of Rs. 59.48 crore in FY24, while its maturing debt obligations were nil over the same period. The current ratio of the company stands healthy at 3.00 times as on March 31, 2024, as against 2.93 times as on March 31, 2023. The liquidity is expected to be strong on the back of nil bank limit utilization in past 12 months giving adequate legroom for growth capital in the form of unutilized bank limits. Company’s nil dependence on external debt shows sufficient opportunity to manage funds for the capex without much compromising the comfortable capital structure of the company. Further the company has unencumbered cash and bank balance of ~Rs. 9.31 Cr. and liquid investments of Rs. 66.62 Cr. further strengthening the liquidity of the company. |
| Outlook: Stable |
|
Acuite believes that the company will continue to derive benefits from its long standing experience in the industry and business synergies with ARIL and will continue to maintain stable business operations. The outlook may be revised to 'Positive' in case the company registers significant improvement in its scale of operations while maintaining comfortable operating profit margin. Conversely the outlook may be revised to 'Negative' in case of failure to achieve scalability amidst intensifying competition in its area of operations or registers deterioration in profitability on account of rising costs and elongation in working capital cycle.
|
| Other Factors affecting Rating |
| None |
| Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
| Operating Income | Rs. Cr. | 381.34 | 379.36 |
| PAT | Rs. Cr. | 52.48 | 56.13 |
| PAT Margin | (%) | 13.76 | 14.80 |
| Total Debt/Tangible Net Worth | Times | 0.00 | 0.00 |
| PBDIT/Interest | Times | 106.52 | 37.26 |
| Status of non-cooperation with previous CRA (if applicable) |
| Not Applicable |
| Any other information |
| None |
| Applicable Criteria |
|
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
| Note on complexity levels of the rated instrument |
|
In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in.
|
|
| |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Contacts |
|
|
|
About Acuité Ratings & Research |
